Community Redevelopment Inc.

2022 Q3 Form 10-Q Financial Statement

#000168316822006096 Filed on August 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $158.2K $271.5K $1.084M
Short-Term Investments
Other Short-Term Assets $146.0K $84.03K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $464.8K $355.5K $1.084M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.146M $0.00 $18.47M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $464.8K $355.5K $1.084M
Total Long-Term Assets $6.146M $0.00 $18.47M
Total Assets $6.610M $355.5K $19.56M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.74K $68.50K $74.10K
YoY Change
Accrued Expenses $10.10K $1.500K $5.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.075M $2.123M $2.154M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.768M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.075M $2.123M $2.154M
Total Long-Term Liabilities $2.768M $0.00
Total Liabilities $7.843M $2.123M $2.154M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$59.35M -$58.19M -$49.28M
YoY Change
Common Stock $28.17K $44.16K $44.08K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.233M -$1.768M $17.40M
YoY Change
Total Liabilities & Shareholders Equity $6.610M $355.5K $19.56M
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45914538 shares
CY2022Q2 us-gaap Cash
Cash
271455 usd
CY2021Q4 us-gaap Cash
Cash
1084486 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
84033 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
355488 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1084486 usd
CY2022Q2 us-gaap Real Estate Investments
RealEstateInvestments
0 usd
CY2021Q4 us-gaap Real Estate Investments
RealEstateInvestments
18471239 usd
CY2022Q2 us-gaap Assets
Assets
355488 usd
CY2021Q4 us-gaap Assets
Assets
19555725 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
68502 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
74098 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1500 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5000 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
35925 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
30092 usd
CY2022Q2 cwnr Convertible Notes Payable Current Net
ConvertibleNotesPayableCurrentNet
383214 usd
CY2021Q4 cwnr Convertible Notes Payable Current Net
ConvertibleNotesPayableCurrentNet
102412 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
634036 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
942458 usd
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1000000 usd
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2123177 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2154060 usd
CY2022Q2 us-gaap Liabilities
Liabilities
2123177 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2154060 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44161538 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44161538 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44077038 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44077038 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
44162 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
44077 usd
CY2022Q2 cwnr Shares To Be Cancelled
SharesToBeCancelled
-10312500 usd
CY2021Q4 cwnr Shares To Be Cancelled
SharesToBeCancelled
0 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66693518 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66633268 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58193869 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Central Index Key
EntityCentralIndexKey
0001084551
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021 cwnr Reverse Split1001 Adjustment
ReverseSplit1001Adjustment
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-208814
dei Entity Registrant Name
EntityRegistrantName
COMMUNITY REDEVELOPMENT INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OK
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2629422
dei Entity Address Address Line1
EntityAddressAddressLine1
1910 Towne Centre Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
#250
dei Entity Address City Or Town
EntityAddressCityOrTown
Annapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21401
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
224-3500
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49276680 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1767689 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
17401665 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
355488 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19555725 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
422560 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
85116 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
721209 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4608886 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
422560 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
85116 usd
us-gaap Operating Expenses
OperatingExpenses
721209 usd
us-gaap Operating Expenses
OperatingExpenses
4608886 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-422560 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-85116 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-721209 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4608886 usd
CY2022Q2 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2021Q2 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
131199 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
37408 usd
us-gaap Interest Expense
InterestExpense
345663 usd
us-gaap Interest Expense
InterestExpense
37408 usd
CY2022Q2 cwnr Change In Fair Value Of Derivative
ChangeInFairValueOfDerivative
-56315 usd
cwnr Change In Fair Value Of Derivative
ChangeInFairValueOfDerivative
308422 usd
cwnr Change In Fair Value Of Derivative
ChangeInFairValueOfDerivative
0 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-187514 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37408 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37241 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37408 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-610074 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-122524 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-758450 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4646294 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-8158739 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-8158739 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8768813 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-122524 usd
us-gaap Net Income Loss
NetIncomeLoss
-8917189 usd
us-gaap Net Income Loss
NetIncomeLoss
-4646294 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44111879 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44111879 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1804341340 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1804341340 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44111879 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44111879 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1804341340 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1804341340 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-778008 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9557117 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
745180 usd
CY2021 cwnr Issuance Of Common Stock Under Merger Agreement Value
IssuanceOfCommonStockUnderMergerAgreementValue
53250000 usd
CY2021 cwnr Issuance Of Preferred Stock Under Merger Agreement Value
IssuanceOfPreferredStockUnderMergerAgreementValue
3000000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-48372624 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
17401665 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60335 usd
cwnr Common Shares To Be Cancelled Under Cancelation Of Merger Agreement
CommonSharesToBeCancelledUnderCancelationOfMergerAgreement
-10312500 usd
us-gaap Net Income Loss
NetIncomeLoss
-8917189 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1767689 usd
us-gaap Profit Loss
ProfitLoss
-8917189 usd
us-gaap Profit Loss
ProfitLoss
-4646294 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-8158739 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
60334 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4491750 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
27620 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
84033 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-5596 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
251 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5834 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3500 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1805 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-813031 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-156098 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
cwnr Increasedecrease In Shareholders Loan
IncreasedecreaseInShareholdersLoan
0 usd
cwnr Increasedecrease In Shareholders Loan
IncreasedecreaseInShareholdersLoan
-38041 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
277778 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
239737 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-813031 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
83639 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1084486 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8518 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271455 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92157 usd
cwnr Common Shares To Be Cancelled Under Cancelation Of Merger Agreement
CommonSharesToBeCancelledUnderCancelationOfMergerAgreement
-10312500 usd
cwnr Common Shares To Be Cancelled Under Cancelation Of Merger Agreement
CommonSharesToBeCancelledUnderCancelationOfMergerAgreement
-0 usd
cwnr Shares Issued For Services
SharesIssuedForServices
60335 usd
cwnr Shares Issued For Services
SharesIssuedForServices
4491750 usd
cwnr Shares Issued To Settle Notes Payable
SharesIssuedToSettleNotesPayable
0 usd
cwnr Shares Issued To Settle Notes Payable
SharesIssuedToSettleNotesPayable
745180 usd
cwnr Cash Paid For Interest
CashPaidForInterest
37083 usd
cwnr Cash Paid For Interest
CashPaidForInterest
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z8u3GO5lCC3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_z34OyXfA3Z7">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include, but are not limited to, revenue recognition, the allowance for bad debt, useful life of fixed assets, income taxes and unrecognized tax benefits, valuation allowance for deferred tax assets, and assumptions used in assessing impairment of long-lived assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The COVID-19 pandemic has caused uncertainty and disruption in the global economy and financial markets. As a result, management’s estimates and assumptions may be subject to a higher degree of variability and volatility that may result in material differences from the current period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zn2QWbo0ao8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_867_z1fkXkEFbwJj">Concentrations of Credit Risk and Off-Balance Sheet Arrangements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash is a financial instrument that potentially subjects the Company to concentrations of credit risk. For all periods presented, substantially all of the Company’s cash was deposited in an account at a single financial institution that management believes is creditworthy. The Company is exposed to credit risk in the event of default by these financial institutions for amounts in excess of the Federal Deposit Insurance Corporation insured limits. The Company maintains its cash at a high-quality financial institution and has not incurred any losses to date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
634036 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
942458 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8917189 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4646294 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44111879 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1804341340 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44111879 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1804341340 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58193869 usd
CY2022Q2 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.075 pure
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-11-30
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44161538 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44161538 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q2 us-gaap Investments
Investments
18471239 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
383214 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
102412 usd
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1000000 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares

Files In Submission

Name View Source Status
0001683168-22-006096-index-headers.html Edgar Link pending
0001683168-22-006096-index.html Edgar Link pending
0001683168-22-006096.txt Edgar Link pending
0001683168-22-006096-xbrl.zip Edgar Link pending
community_ex3101.htm Edgar Link pending
community_ex3102.htm Edgar Link pending
community_ex3201.htm Edgar Link pending
community_ex3202.htm Edgar Link pending
community_i10q-063022.htm Edgar Link pending
cwnr-20220630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
cwnr-20220630_cal.xml Edgar Link unprocessable
cwnr-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cwnr-20220630_lab.xml Edgar Link unprocessable
cwnr-20220630_pre.xml Edgar Link unprocessable
community_i10q-063022_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending